Abstract: A compound of general Formula (I) having histone deacetylase (HDAC) and/or CDK inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.
Type:
Grant
Filed:
July 14, 2009
Date of Patent:
January 1, 2013
Assignee:
Gilead Sciences, Inc.
Inventors:
Michael Graupe, Chandrasekar Venkataramani